- Q1 2024 Kymera Therapeutics Inc Earnings Call TranscriptMay 02, 2024$36.3 (+0.17%)Earnings
- Q4 2023 Kymera Therapeutics Inc Earnings Call TranscriptFeb 22, 2024$40.49 (+4.71%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Kymera Therapeutics Inc Virtual Immunology R&D Day TranscriptJan 04, 2024
- Kymera Therapeutics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Kymera Therapeutics Inc Earnings Call TranscriptNov 02, 2023$12.08 (+4.59%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Kymera Therapeutics Inc Earnings Call TranscriptAug 03, 2023$23.88 (+11.07%)Earnings
- Kymera Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Kymera Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Kymera Therapeutics Inc Earnings Call TranscriptMay 04, 2023$26.24 (-15.08%)Earnings
- Q4 2022 Kymera Therapeutics Inc Earnings Call TranscriptFeb 23, 2023$33.16 (+5.17%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Kymera Therapeutics Inc Investor Webcast KT-474 Clinical Update Call TranscriptDec 14, 2022
- Kymera Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kymera Therapeutics Inc Earnings Call TranscriptNov 03, 2022$30.92 (+7.55%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Kymera Therapeutics Inc Earnings Call TranscriptAug 09, 2022$30.35 (-3.44%)Earnings
- Kymera Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Kymera Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Kymera Therapeutics Inc Earnings Call TranscriptMay 03, 2022$24.88 (-23.98%)Earnings
- Kymera Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Kymera Therapeutics Inc To Host Virtual R&D Day TranscriptDec 16, 2021
- Kymera Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Kymera Therapeutics Inc To Discuss Data From KT-474 Phase 1 Trial Call TranscriptOct 27, 2021
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Kymera Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Kymera Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Kymera Therapeutics Inc Presenting at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
Kymera Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Hi, everyone. Welcome back to Day 4 of the 2021 Credit Suisse Healthcare Conference. I'm Judah Frommer. I cover biotech here at CS, and we're happy to have Kymera with us. They'll start out with a presentation, and then we'll have some time for Q&A after. So Nello, why don't I pass it over to you?
Thanks, Judah. So thanks for the invitation. Great to be here. So what I thought I would do, just go through some slides maybe for the first 20, 25 minutes, and then we can leave time for questions. The team is online as well, if needed. So let me put the slides. So hopefully, that's visible to the audience.
So again, thanks for the invite. The goal today is just over a bit of history and why Kymera was founded, but then spend most of the time providing an update on what we've done really in the past, I would say a few weeks, if not months, and what we're expecting to see
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)